2011Journal of clinical and experimental medicineRequires access

Analysis of the clinical distribution and drug resistance of Pseudomonas aeruginosa in our hosipital in 2010

Wang Hou-zhao

Open publisher page 0 citations

Abstract

Objective To investigate the clinical distribution and drug resistance of Pseudomonas aeruginosa(P.aeruginosa) in our hospital in order to offer reference to control nosocomial infection and guide drug treatment in clinic.Methods The strains and drug resistance of P.aeruginosa were detected by Walkaway automatic bacterium identifying and drug sensitivity analyzing systems,and the drug resistance was analyzed.Results P.aeruginosa were mainly isolated from patients in Department of Thoracic Surgery(34.83%) and Department of Neurosurgery(20.22%).Among the 178 specimens,the dominant specimen was sputum(49.44%).The drug resistant rates to most antibacterials were high,and showed low drug resistant rate to piperacillin/tazobactam,cefoperazone/sulbactam and imipenem.Conclusion P.aeruginosa is multi-drug resistant.Rational application of antibiotics and standard prevention should be strengthened to control the nosocomial infection caused by P.aeruginosa.

About this research paper

What this paper is about

Objective To investigate the clinical distribution and drug resistance of Pseudomonas aeruginosa(P.aeruginosa) in our hospital in order to offer reference to control nosocomial infection and guide drug treatment in clinic.Methods The strains and drug resistance of P.aeruginosa were detected by Walkaway automatic bacterium identifying and drug sensitivity analyzing systems,and the drug resistance was analyzed.Results P.aeruginosa were mainly isolated from patients in Department of Thoracic Surgery(34.83%) and Department of Neurosurgery(20.22%).Among the 178 specimens,the dominant specimen was sputum(49.44%).The drug resistant rates to most antibacterials were high,and showed low drug resistant rate to piperacillin/tazobactam,cefoperazone/sulbactam and imipenem.Conclusion P.aeruginosa is multi-drug resistant.Rational application of antibiotics and standard prevention should be strengthened to control the nosocomial infection caused by P.aeruginosa.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the clinical distribution and drug resistance of Pseudomonas aeruginosa(P.aeruginosa) in our hospital in order to offer reference to control nosocomial infection and guide drug treatment in clinic.Methods The strains and drug resistance of P.aeruginosa were detected by Walkaway automatic bacterium identifying and drug sensitivity analyzing systems,and the drug resistance was analyzed.Results P.aeruginosa were mainly isolated from patients in Department of Thoracic Surgery(34.83%) and Department of Neurosurgery(20.22%).Among the 178 specimens,the dominant specimen was sputum(49.44%).The drug resistant rates to most antibacterials were high,and showed low drug resistant rate to piperacillin/tazobactam,cefoperazone/sulbactam and imipenem.Conclusion P.aeruginosa is multi-drug resistant.Rational application of antibiotics and standard prevention should be strengthened to control the nosocomial infection caused by P.aeruginosa.

Key concepts: Medicine, Pseudomonas aeruginosa, Cefoperazone, Drug resistance, Imipenem, Sulbactam, Tazobactam, Piperacillin

Related papers

Back to paper searchBrowse research topicsOriginal source
Analysis of the clinical distribution and drug resistance of Pseudomonas aeruginosa in our hosipital in 2010 — Research Paper | ScholarLens